Symptoms of hypoglycaemia in people with diabetes

Diabetic Medicine

Volumn 18, Issue 9, 2001, Pages 690-705

  McAulay, V ^a   Deary, I J ^a   Frier, Brian M ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Diabetes mellitus; Hypoglycaemia; Hypoglycaemia symptoms; Hypoglycaemia unawareness

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; INSULIN; MEGLITINIDE; METHYLXANTHINE; SULFONYLUREA; TERBUTALINE; THEOPHYLLINE;

CLINICAL FEATURE; CLINICAL PRACTICE; CONFUSION; DROWSINESS; GLUCOSE BLOOD LEVEL; HEADACHE; HEART PALPITATION; HUMAN; HUNGER; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; REVIEW; RISK FACTOR; SWEATING; SYMPTOM;

AGED; AGING; AUTONOMIC NERVOUS SYSTEM; AWARENESS; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY;

EID: 0034797567     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00620.x     Document Type: Review

References (121)

1. Glucose counterregulation: The prevention and correction of hypoglycemia in humans
2. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects
3. Glycemic thresholds for activation of glucose counterregulatory symptoms are higher than the threshold for symptoms
4. Hypoglycemia in IDDM
5. Multi-factorial origin of hypoglycemic symptom awareness in IDDM
6. Haemodynamic responses and functional changes in major organs
7. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: No causal relation with diabetic autonomic neuropathy
8. Symptomatic hypoglycaemia in 411 type 1 diabetic patients
9. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia
10. Hypoglycemia unawareness
11. Impaired hypoglycaemia awareness
12. Counterregulatory failure
13. The prevalence of impaired glucose counter-regulation during an insulin-infusion test in insulin-treated diabetic patients prone to severe hypoglycaemia
14. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive insulin therapy
15. Hypoglycaemia
16. Recovery mechanisms from acute hypoglycaemia in complete tetraplegia
17. Physiological responses to insulin hypoglycaemia in spinal man
18. Effects of insulin after adrenalectomy
19. Insulin hypoglycaemia in normal and adrenalectomised subjects: Comparison of metabolic parameters and endocrine counter-regulation
20. The role of adrenaline in hypoglycaemic reactions in man
21. Peripheral β-adrenergic receptors concerned with tremor
22. Low plasma concentrations of adrenaline and physiological tremor in man
23. A randomised, double-blind placebo controlled trial of the effects of Metoprolol CR, Atenolol and Propranolol LA on the physiological responses to hypoglycaemia in non-diabetic subjects
24. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms
25. Cholinergic manifestations of the acute autonomic reaction to hypoglycaemia in man
26. Ingestion in the satiated rat: Role of alpha- and beta-receptors in mediating effects of hypothalamic adrenergic stimulation
27. Attempt at pharmacological differentiation of central beta-adrenergic receptors
28. Integration of energy intake and expenditure in animals and man: The autonomic and adrenal hypothesis
29. Hypothalamic alpha 2 and beta-adrenoceptor rhythm are correlated with circadian feeding: Evidence from chronic methamphetamine treatment and withdrawal
30. Symptoms of hypoglycaemia
31. Hypoglycemic symptoms and decreased β-adrenergic sensitivity in insulin-dependent diabetic patients
32. Influence of human insulin on symptoms and awareness of hypoglycaemia: A randomised double blind crossover trial
33. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach
34. Classification of the symptoms of hypoglycaemia in insulin-treated diabetic patients using factor-analysis: Relationship to hypoglycaemia unawareness
35. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis
36. Physical symptoms related to blood glucose in insulin-dependent diabetics
37. Reliability of symptom-blood glucose relationships among insulin-dependent adult diabetics
38. Accuracy of perceiving blood glucose in IDDM
39. Perceived symptoms in the recognition of hypoglycemia
40. Professionals' beliefs about useful symptoms of hypoglycaemia
41. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction
42. A biopsychobehavioral model of risk of severe hypoglycemia
43. Sex differences in plasma glucose thresholds for counterregulatory hormone release and hypoglycemia symptom perception
44. Glycaemic thresholds for hypoglycaemic responses in obese subjects
45. Counterregulatory adaptation to recurrent hypoglycemia in normal humans
46. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans
47. Intermittent hypoglycemia impairs glucose counterregulation
48. Induction of hypoglycemia unawareness by asymptomatic hypoglycemia
49. Effect of antecedent hypoglycemia on cognitive function and on glycemic thresholds for counterregulatory hormone secretion in healthy humans
50. Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients
51. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus
52. Brief twice weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type I diabetes mellitus
53. Preserved counterregulatory hormone release and symptoms after short term hypoglycemic episodes in normal men
54. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans
55. Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM
56. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus
57. Altered recognition of hypoglycaemia symptoms in Type I diabetes during intensified control with continuous subcutaneous insulin infusion
58. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release
59. Lack of protection of higher brain function during hypoglycaemia in patients with intensively treated IDDM
60. Independent effects of youth and poor diabetes control on responses to hypoglycemia in children
61. Insulin reactions. Manifestations and need for recognition of long-acting insulin reactions
62. Hypoglycemia unawareness in IDDM
63. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics
64. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes
65. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics
66. Nocturnal hypoglycaemia in patients receiving conventional treatment with insulin
67. Incidence of nocturnal hypoglycaemia in insulin-dependent diabetic patients on intensive therapy
68. Improved counter-regulatory hormonal and symptomatic responses to hypoglycaemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycaemic control
69. Reversibility of unawareness of hypoglycaemia in patients with insulinomas
70. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes
71. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM
72. Reversal of hypoglycemia unawareness, but not counterregulation, in IDDM
73. Recovery of epinephrine response but not hypoglycemic threshold after intensive therapy in type 1 diabetes
74. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM
75. Increased symptoms of hypoglycaemia in the standing position in insulin-dependent diabetes mellitus
76. Physiological and symptomatic responses to postural change in nondiabetic subjects during hypoglycaemia
77. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with Type I (insulin-dependent) diabetes
78. Effect of caffeine on the recognition of and responses to hypoglycemia in humans
79. Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes
80. Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes
81. Drugs and alcohol
82. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM
83. Theophylline enhances glucose recovery after hypoglycemia in healthy men and in type 1 diabetic subjects
84. Symptom awareness is affected by the subjects' expectations during insulin-induced hypoglycemia
85. Unsuspected hypoglycaemia, haemoglobin A1 and diabetic control
86. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: Assessment by means of semiambulatory 24 hour continuous blood glucose monitoring
87. The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients
88. Effects and correlates of blood glucose awareness training among patients with IDDM
89. A multicentre evaluation of blood glucose awareness training - II
90. Documented symptomatic hypoglycaemia in children and adolescents using multiple daily insulin injection therapy
91. The influence of puberty on counterregulatory responses to hypoglycaemia in children and young adults with insulin-dependent diabetes mellitus (IDDM)
92. Symptomatic hypoglycaemia in childhood diabetes: A population-based questionnaire study
93. A prospective study of symptomatic hypoglycaemia in childhood diabetes
94. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children
95. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM
96. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus
97. Counterregulatory hormone and symptom responses to hypoglycaemia in diabetic children
98. Symptoms of hypoglycemia in children with IDDM
99. Hypoglycaemic symptoms reported by children with type 1 diabetes mellitus and by their parents
100. Perceptions of hypoglycaemia in childhood diabetes mellitus: A questionnaire study
101. Reduced awareness of hypoglycaemia in the elderly despite an intact counterregulatory response
102. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men
103. Altered responses to hypoglycemia of healthy elderly people
104. Is it a hypo? Knowledge of symptoms of hypoglycaemia in elderly diabetic patients
105. Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients
106. Perceived symptoms of hypoglycaemia in elderly Type 2 diabetic patients treated with insulin
107. Severe hypoglycaemia during pregnancy, its frequency and predisposing factors in diabetic women
108. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type 1 diabetic women
109. Hormonal counterregulation and subjective symptoms during induced hypoglycaemia in insulin-dependent diabetes mellitus patients during and after pregnancy
110. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents
111. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects
112. Frequency and symptoms of hypoglycaemia experienced by patients with Type 2 diabetes treated with insulin
113. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM
114. Hypoglycaemia and Type II diabetes: Sulphonylureas
115. Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM
116. Insulin-associated modulation of neuroendocrine counterregulation, hypoglycemia perception, and cerebral function in insulin-dependent diabetes mellitus: Evidence for an intrinsic effect of insulin on the central nervous system
117. Symptoms, hormones and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs venous insulin infusion in type 1 diabetes
118. Human insulin and hypoglycaemia: A literature survey
119. Hypoglycaemia induced by exogenous insulin - 'Human' and animal insulin compared